Inhibikase Therapeutics IKT Revenue Breakdown

NASDAQ IKT
$1.63 -0.03 (-1.81%)
At close: Oct 22, 2026 · 4:00 PM EDT
No revenue breakdown for IKT Inhibikase Therapeutics does not report revenue split by segment, product or geography.